251
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Alkaloids of Adhatoda vasica Nees. as potential inhibitors of cyclooxygenases – an in-silico study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 7245-7255 | Received 26 Dec 2020, Accepted 22 Feb 2021, Published online: 10 Mar 2021

References

  • Abdur Rahim, M., Praveen Rao, P. N., Bhardwaj, A., Kaur, J., Huang, Z., & Knaus, E. E. (2011). Isomeric acetoxy analogs of celecoxib and their evaluation as cyclooxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters, 21(20), 6074–6080. https://doi.org/10.1016/j.bmcl.2011.08.053
  • Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
  • Amala, R., & Sujatha, S. (2021). Presence of pyrroloquinazoline alkaloid in Adhatoda vasica attenuates inflammatory response through the downregulation of pro-inflammatory mediators in LPS stimulated RAW 264.7 macrophages. BioImpacts: BI, 11(1), 15–22. https://doi.org/10.34172/bi.2021.03
  • Anandakrishnan, R., Aguilar, B., & Onufriev, A. V. (2012). H++ 3.0: Automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Research, 40(W1), 537–541.
  • Attiq, A., Jalil, J., Husain, K., & Ahmad, W. (2018). Raging the war against inflammation with natural products. Frontiers in Pharmacology, 9, 1–27.
  • Berendsen, H. J. C., Postma, J. P. M., Van Gunsteren, W. F., Dinola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
  • Cerella, C., Sobolewski, C., Dicato, M., & Diederich, M. (2010). Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy. Biochemical Pharmacology, 80(12), 1801–1815. https://doi.org/10.1016/j.bcp.2010.06.050
  • Chaudhary, N., & Aparoy, P. (2020). Application of per-residue energy decomposition to identify the set of amino acids critical for in silico prediction of COX-2 inhibitory activity. Heliyon, 6(10), e04944. https://doi.org/10.1016/j.heliyon.2020.e04944
  • Choi, S. H., Aid, S., & Bosetti, F. (2009). The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: Implications for translational research. Trends in Pharmacological Sciences, 30(4), 174–181. https://doi.org/10.1016/j.tips.2009.01.002
  • Cryer, B., & Feldman, M. (1998). Cyclooxygenase-1 and Cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. The American Journal of Medicine, 104(5), 413–421. https://doi.org/10.1016/S0002-9343(98)00091-6
  • Dannhardt, G., & Kiefer, W. (2001). Cyclooxygenase inhibitors-current status and future prospects. European Journal of Medicinal Chemistry, 36(2), 109–126. https://doi.org/10.1016/s0223-5234(01)01197-7
  • Dennis, E. A., & Norris, P. C. (2015). Eicosanoid storm in infection and inflammation. Nature Reviews. Immunology, 15(8), 511–523. https://doi.org/10.1038/nri3859
  • Duan, L., Liu, X., & Zhang, J. Z. H. (2016). Interaction entropy: A new paradigm for highly efficient and reliable computation of protein-ligand binding free energy. Journal of the American Chemical Society, 138(17), 5722–5728. https://doi.org/10.1021/jacs.6b02682
  • Froimowitz, M. (1993). HyperChem: A software package for computational chemistry and molecular modeling. BioTechniques, 14(6), 1010–1013.
  • Ghanta, P., Sinha, S., Doble, M., & Ramaiah, B. (2020). Potential of pyrroquinazoline alkaloids from Adhatoda vasica Nees. as inhibitors of 5-LOX – a computational and an in-vitro study. Journal of Biomolecular Structure and Dynamics, 0(0), 1–12.
  • Gupta, A., & Prajapati, P. (2010). A clinical review of different formulations of Vasa (Adhatoda vasica) on Tamaka Shwasa (asthma). AYU (An International Quarterly Journal of Research in Ayurveda), 31(4), 520–524. https://doi.org/10.4103/0974-8520.82032
  • Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
  • Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature, 444(7121), 860–867. https://doi.org/10.1038/nature05485
  • Huang, K., Luo, S., Cong, Y., Zhong, S., Zhang, J. Z. H., & Duan, L. (2020). An accurate free energy estimator: Based on MM/PBSA combined with interaction entropy for protein-ligand binding affinity. Nanoscale, 12(19), 10737–10750. https://doi.org/10.1039/c9nr10638c
  • Hudson, N., Balsitis, M., Everitt, S., & Hawkey, C. J. (1993). Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut, 34(6), 742–747. https://doi.org/10.1136/gut.34.6.742
  • Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
  • Jin, H., Lee, J., Lee, D., Hong, Y., Kim, Y., & Lee, J. (2004). Inhibitors of the LPS-induced NF-kappaB activation from Artemisia sylvatica. Phytochemistry, 65(15), 2247–2253. https://doi.org/10.1016/j.phytochem.2004.06.034
  • Jovanovic, D. V., Fernandes, J. C., Martel-Pelletier, J., Jolicoeur, F.-C., Reboul, P., Laufer, S., Tries, S., & Pelletier, J.-P. (2001). In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis: Suppression of collagenase 1 and interleukin-1? synthesis. Arthritis & Rheumatism, 44(10), 2320–2330. https://doi.org/10.1002/1529-0131(200110)44:10<2320::AID-ART394>3.0.CO;2-P
  • Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–13. https://doi.org/10.1093/nar/gkv951
  • Knights, K. M., Mangoni, A. A., & Miners, J. O. (2010). Defining the COX inhibitor selectivity of NSAIDs: Implications for understanding toxicity. Expert Review of Clinical Pharmacology, 3(6), 769–776. https://doi.org/10.1586/ecp.10.120
  • Kumari, R., Kumar, R., & Lynn, A., Open Source Drug Discovery Consortium (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
  • Lajter, I., Pan, S.-P., Nikles, S., Ortmann, S., Vasas, A., Csupor-Löffler, B., Forgó, P., Hohmann, J., & Bauer, R. (2015). Inhibition of COX-2 and NF-κB1 Gene Expression, NO Production, 5-LOX, and COX-1 and COX-2 enzymes by extracts and constituents of Onopordum acanthium. Planta Medica, 81(14), 1270–1276. https://doi.org/10.1055/s-0035-1546242
  • Lee, D., Cuendet, M., Vigo, J. S., Graham, J. G., Cabieses, F., Fong, H. H., Pezzuto, J. M., & Kinghorn, A. D. (2001). A novel cyclooxygenase-inhibitory stilbenolignan from the seeds of Aiphanes aculeata. Organic Letters, 3(14), 2169–2171. https://doi.org/10.1021/ol015985j
  • Liu, W., Wang, Y., He, D., Li, S., Zhu, Y., & Jiang, B. (2015). Antitussive, expectorant, and bronchodilating effects of quinazoline alkaloids (±)-vasicine, deoxyvasicine, and (±)-vasicinone from aerial parts of Peganum harmala L. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 22(12), 1088–1095. https://doi.org/10.1016/j.phymed.2015.08.005
  • Mamta, P., Sujata, B. & Rachana. (2013). Anti-oxidant activity and cytoprotective potential of ethanolic extract of Adhatoda vasica. International Journal PharmTech, Research, 5(2), 501–510.
  • Mark, P., & Nilsson, L. (2001). Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954–9960. https://doi.org/10.1021/jp003020w
  • Mehta, D. R., Naravane, J. S., & Desai, R. M. (1963). Vasicinone. A bronchodilator principle from Adhatoda Vasica Nees (N. O. Acanthaceae). The Journal of Organic Chemistry, 28(2), 445–448. https://doi.org/10.1021/jo01037a041
  • Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
  • Orlando, B. J., & Malkowski, M. G. (2016). Substrate-selective inhibition of cyclooxygeanse-2 by fenamic acid derivatives is dependent on peroxide tone. The Journal of Biological Chemistry, 291(29), 15069–15081. https://doi.org/10.1074/jbc.M116.725713
  • Parrinello, M., Rahman, A., & Vashishta, P. (1983). Structural transitions in superionic conductors. Physical Review Letters, 50(14), 1073–1076. https://doi.org/10.1103/PhysRevLett.50.1073
  • Price, M. L. P., & Jorgensen, W. L. (2001). Rationale for the observed COX-2/COX-1 selectivity of celecoxib from Monte Carlo simulations. Bioorganic & Medicinal Chemistry Letters, 11(12), 1541–1544. https://doi.org/10.1016/S0960-894X(00)00522-9
  • Prochazkova, M., Dolezal, T., Sliva, J., & Krsiak, M. (2006). Different patterns of spinal cyclooxygenase-1 and cyclooxygenase-2 mRNA expression in inflammatory and postoperative pain. Basic Clinical Pharmacology Toxicology, 99(2), 173–177. https://doi.org/10.1111/j.1742-7843.2006.pto_457.x
  • PyMOL. (XXXX). The PyMOL Molecular Graphics System, Version 2.x, Schrödinger, LLC. https://pymol.org/2/support.html?
  • Rimon, G., Sidhu, R. S., Lauver, D. A., Lee, J. Y., Sharma, N. P., Yuan, C., Frieler, R. A., Trievel, R. C., Lucchesi, B. R., & Smith, W. L. (2010). Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1. Proceedings of the National Academy of Sciences of the United States of America, 107(1), 28–33. https://doi.org/10.1073/pnas.0909765106
  • Seeliger, D., & de Groot, B. L. (2010). Ligand docking and binding site analysis with PyMOL and Autodock/Vina. Journal of Computer-Aided Molecular Design, 24(5), 417–422. https://doi.org/10.1007/s10822-010-9352-6
  • Sharafkhaneh, A., Velamuri, S., Badmaev, V., Lan, C., & Hanania, N. (2007). Review: The potential role of natural agents in treatment of airway inflammation. Therapeutic Advances in Respiratory Disease, 1(2), 105–120. https://doi.org/10.1177/1753465807086096
  • Singh, A., Kumar, S., Reddy, T. J., Rameshkumar, K. B., & Kumar, B. (2015). Screening of tricyclic quinazoline alkaloids in the alkaloidal fraction of Adhatoda beddomei and Adhatoda vasica leaves by high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Rapid Communications in Mass Spectrometry: RCM, 29(6), 485–496. https://doi.org/10.1002/rcm.7126
  • Singh, B., & Sharma, R. A. (2013). Anti-inflammatory and antimicrobial properties of pyrroloquinazoline alkaloids from Adhatoda vasica Nees. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 20(5), 441–445. https://doi.org/10.1016/j.phymed.2012.12.015
  • Singh, V. K., Mishra, V., Tiwari, S., Khaliq, T., Barthwal, M. K., Pandey, H. P., Palit, G., & Narender, T. (2013). Anti-secretory and cyto-protective effects of peganine hydrochloride isolated from the seeds of Peganum harmala on gastric ulcers. Phytomedicine: international Journal of Phytotherapy and Phytopharmacology, 20(13), 1180–1185. https://doi.org/10.1016/j.phymed.2013.06.017
  • Somvanshi, R. K., Kumar, A., Kant, S., Gupta, D., Singh, S. B., Das, U., Srinivasan, A., Singh, T. P., & Dey, S. (2007). Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent. Biochemical and Biophysical Research Communications, 361(1), 37–42. https://doi.org/10.1016/j.bbrc.2007.06.122
  • Søndergaard, L. (1993). Homology between the mammalian liver and the Drosophila fat body. Trends in Genetics: TIG, 9(6), 193–193. https://doi.org/10.1016/0168-9525(93)90113-v
  • Soni, S., Anandjiwala, S., Patel, G., & Rajani, M. (2008). Validation of different methods of preparation of Adhatoda vasica leaf juice by quantification of total alkaloids and vasicine. Indian Journal of Pharmaceutical Sciences, 70(1), 36–42. https://doi.org/10.4103/0250-474X.40329
  • Sousa Da Silva, A. W., & Vranken, W. F. (2012). ACPYPE - AnteChamber PYthon Parser interfacE. BMC Research Notes, 5(1), 367–368. https://doi.org/10.1186/1756-0500-5-367
  • Suthar, S. K., & Sharma, M. (2015). Recent developments in chimeric NSAIDs as safer anti-inflammatory agents. Medicinal Research Reviews, 35(2), 341–407. https://doi.org/10.1002/med.21331
  • The Editors of Encyclopaedia Britannica. (2020). Charaka-samhita [Internet]. Encyclopaedia Britannica. [cited (2020). Dec 12]. https://www.britannica.com/topic/Charaka-samhita
  • Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455-61. https://doi.org/10.1002/jcc.21334
  • Vane, J. R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New Biology, 231(25), 232–235. https://doi.org/10.1038/newbio231232a0
  • Viegas, A., Manso, J., Corvo, M. C., Marques, M. M. B., & Cabrita, E. J. (2011). Binding of Ibuprofen, Ketorolac, and Diclofenac to COX-1 and COX-2 studied by saturation transfer difference NMR. Journal of Medicinal Chemistry, 54(24), 8555–8562. https://doi.org/10.1021/jm201090k
  • Wallace, J. L. (2019). Eicosanoids in the gastrointestinal tract. British Journal of Pharmacology, 176(8), 1000–1008. https://doi.org/10.1111/bph.14178
  • Wallace, J. L., & Keenan, C. M. (1990). An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. The American Journal of Physiology, 258(4 Pt 1), G527–34. https://doi.org/10.1152/ajpgi.1990.258.4.G527
  • Wang, J. L., Limburg, D., Graneto, M. J., Springer, J., Hamper, J. R. B., Liao, S., Pawlitz, J. L., Kurumbail, R. G., Maziasz, T., Talley, J. J., Kiefer, J. R., & Carter, J. (2010). The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life. Bioorganic & Medicinal Chemistry Letters, 20(23), 7159–7163. https://doi.org/10.1016/j.bmcl.2010.07.054
  • Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999). Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proceedings of the National Academy of Sciences of the United States of America, 96(13), 7563–7568. https://doi.org/10.1073/pnas.96.13.7563
  • Wolfe, J. A., Plotzker, R., Safina, F. J., Ross, M., Popky, G., & Rubin, W. (1976). Gastritis, duodenitis, and bleeding duodenal ulcer following mefenamic acid therapy. Archives of Internal Medicine, 136(8), 923–925.
  • Yedgar, S., Krimsky, M., Cohen, Y., & Flower, R. J. (2007). Treatment of inflammatory diseases by selective eicosanoid inhibition: A double-edged sword? Trends in Pharmacological Sciences, 28(9), 459–464. https://doi.org/10.1016/j.tips.2007.07.005
  • Yoshikawa, K., Inoue, M., Matsumoto, Y., Sakakibara, C., Miyataka, H., Matsumoto, H., & Arihara, S. (2005). Lanostane triterpenoids and triterpene glycosides from the fruit body of Fomitopsis pinicola and their inhibitory activity against COX-1 and COX-2. Journal of Natural Products, 68(1), 69–73. https://doi.org/10.1021/np040130b
  • Zhang, J., Zhang, Q., Chen, X., Liu, Y., Xue, J., Dahan, A., Zhang, H., & Chai, Y. (2018). Revealing synergistic mechanism of multiple components in Gandi capsule for diabetic nephropathy therapeutics by network pharmacology. Evidence-Based Complementary and Alternative Medicine, 2018, 1–11. https://doi.org/10.1155/2018/6503126

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.